From denials and payer plans for unilateral downcoding to 340B legal battles, the most-read stories of 2025 reveal a revenue cycle under pressure, and the strategies leaders are using to stay afloat.
As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback